• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症:类固醇和单克隆抗体在治疗中的作用。

Sepsis: the role of steroids and monoclonal antibodies in treatment.

作者信息

Manzullo E F

机构信息

Section of General Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston.

出版信息

Oncology (Williston Park). 1994 Jun;8(6):115-20; discussion 120, 123.

PMID:8074977
Abstract

Septic shock is currently the most common cause of death in noncoronary intensive care units in the United States. The pathogenesis of sepsis involves a variety of cytokine and noncytokine mediators, which, when activated, can result in a self-perpetuating cascade. This systemic response to infection is a frequent cause of multi-organ system failure and death. Treatment has traditionally focused on antibiotic therapy, but this has not significantly changed patient outcomes. Steroids have been shown to be of little or no value and studies evaluating monoclonal antibodies that target the mediators of the sepsis cascade have not produced promising results.

摘要

在美国,感染性休克目前是非冠状动脉重症监护病房中最常见的死亡原因。脓毒症的发病机制涉及多种细胞因子和非细胞因子介质,这些介质一旦被激活,可导致一种自我持续的级联反应。这种对感染的全身反应是多器官系统衰竭和死亡的常见原因。传统上,治疗主要集中在抗生素治疗上,但这并没有显著改变患者的预后。已证明类固醇几乎没有价值或毫无价值,评估针对脓毒症级联反应介质的单克隆抗体的研究也未取得有前景的结果。

相似文献

1
Sepsis: the role of steroids and monoclonal antibodies in treatment.脓毒症:类固醇和单克隆抗体在治疗中的作用。
Oncology (Williston Park). 1994 Jun;8(6):115-20; discussion 120, 123.
2
The definition of septic shock: implications for treatment.脓毒症休克的定义:对治疗的启示
Crit Care Resusc. 2007 Mar;9(1):101-3.
3
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.严重脓毒症和脓毒性休克的最佳治疗:支持这些建议的证据
Dis Mon. 2004 Apr;50(4):168-213. doi: 10.1016/j.disamonth.2003.12.003.
4
Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.急诊科早期目标导向治疗、皮质类固醇及重组人活化蛋白C治疗严重脓毒症和脓毒性休克
Acad Emerg Med. 2006 Jan;13(1):109-13. doi: 10.1197/j.aem.2005.08.005. Epub 2005 Dec 19.
5
The current management of septic shock.感染性休克的当前管理
Minerva Med. 2008 Oct;99(5):431-58.
6
[Severe sepsis and septic shock].[严重脓毒症和脓毒性休克]
Rev Med Suisse. 2006 Apr 5;2(60):896-8, 900-2.
7
[Immunotherapy of sepsis and septic shock].
Lijec Vjesn. 1995 Jun;117 Suppl 2:8-11.
8
Therapeutic plasma exchange in severe sepsis or septic shock.严重脓毒症或脓毒性休克中的治疗性血浆置换
Acta Med Croatica. 1998;52(2):127-32.
9
[Sepsis in the critically-ill patient].[危重症患者的脓毒症]
Ugeskr Laeger. 2007 Feb 19;169(8):703-5.
10
Pharmacological treatment of sepsis.脓毒症的药物治疗
Fundam Clin Pharmacol. 2008 Aug;22(4):355-61. doi: 10.1111/j.1472-8206.2008.00606.x.

引用本文的文献

1
Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia.单次输注髓系祖细胞可降低化疗诱导的中性粒细胞减少后烟曲霉感染导致的死亡。
Blood. 2005 May 1;105(9):3535-7. doi: 10.1182/blood-2004-07-2676. Epub 2004 Dec 2.